Cover Image
市場調查報告書

神經性疼痛:主要15個市場的預測 2016-2026年

Neuropathic Pain Forecast in 15 Major Markets 2016-2026

出版商 Black Swan Analysis 商品編碼 349942
出版日期 內容資訊 英文 56 Pages
訂單完成後即時交付
價格
Back to Top
神經性疼痛:主要15個市場的預測 2016-2026年 Neuropathic Pain Forecast in 15 Major Markets 2016-2026
出版日期: 2016年01月18日 內容資訊: 英文 56 Pages
簡介

神經性疼痛一般定義為起因於神經系統損傷的慢性疼痛。神經性疼痛由糖尿病和帶狀皰疹感染疾病等,其他疾病引起,往往伴隨憂鬱症,睡眠障礙和恐怖/不安。

本報告提供主要15個市場 (美國、法國、德國、義大利、西班牙、英國、巴西、日本、印度、墨西哥、土耳其、荷蘭、澳洲、加拿大及波蘭) 的神經性疼痛的目前患者數 (性別、各年齡世代) 調查分析、目前盛行率,加上疾病概要、危險因素、疾病診斷預後、主要的症狀和併發症等系統性資訊。

圖表

簡介

病因

危險因素和預防

疾病診斷

變異:各地區/民族

疾病預後和臨床過程

疾病相關的主要併發症/特徵

定量化患者數的手法

  • 按照要求可使用的追加資料

神經性疼痛的盛行率top line

神經性疼痛患者的特徵

  • 神經性疼痛的重病度
  • 神經性疼痛的原因論

神經性疼痛的症狀

  • 神經性疼痛的位置、持續期間
  • 神經性疼痛的身體感覺

簡稱

相關出版

患者為基礎的線上資料庫

患者為基礎的產品

價格的線上資料、平台

參考文件

附錄

目錄
Product Code: NEPA0010116

image1

Neuropathic pain is generally defined as chronic pain resulting from injury to the nervous system. Neuropathic pain is caused by other conditions or diseases such as diabetes or herpes zoster infection, and is often accompanied by depression, sleep disturbances and fear/anxiety. Nerve fibres may be damaged or dysfunctional, causing incorrect signals to other pain centres.

This report provides the current prevalent population for Neuropathic Pain across 15 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Mexico, Turkey, Netherlands, Australia, Canada and Poland) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Neuropathic Pain have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Neuropathic Pain include:

  • Abnormal sensations - e.g. paresthesia, allodynia, algesia
  • Myelomas and some forms of Non-Hodgkin Lymphoma
  • Type 2 Diabetes Mellitus
  • Herpes zoster (shingles)
  • Chronic lower back pain
  • Multiple sclerosis

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Neuropathic Pain's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Neuropathic Pain and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Neuropathic Pain's prevalent population.
  • Identify sub-populations within Neuropathic Pain which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Neuropathic Pain patients.

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

Key Co-morbid Conditions /Features Associated with the Disease

Methodology for Quantification of Patient Numbers

  • Additional data available on request

Top-Line Prevalence for Neuropathic Pain

Features of Neuropathic Pain Patients

  • Severity of Neuropathic Pain
  • Aetiology of Neuropathic Pain

Symptoms of Neuropathic Pain

  • Location and Duration of Neuropathic Pain
  • Physical Sensations of Neuropathic Pain

Abbreviations and Acronyms used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables

  • 1. Prevalence of Neuropathic Pain, total (000s)
  • 2. Prevalence of Neuropathic Pain, males (000s)
  • 3. Prevalence of Neuropathic Pain, females (000s)
  • 4. Severity of Neuropathic Pain in patients, total (000s)
  • 5. Aetiology of Neuropathic Pain, total (000s)
  • 6. Months (M) of Pain duration in Neuropathic Pain patients, total (000s)
  • 7. Prevalence of upper limb pain in Neuropathic Pain patients, total (000s)
  • 8. Prevalence of lower limb pain in Neuropathic Pain patients, total (000s)
  • 9. Prevalence of neck/shoulder pain in Neuropathic Pain patients, total (000s)
  • 10. Prevalence of numbness feeling in Neuropathic Pain patients, total (000s)
  • 11. Prevalence of squeezing feeling in Neuropathic Pain patients, total (000s)
  • 12. Prevalence of lancinating feeling in Neuropathic Pain patients, total (000s)
  • 13. Abbreviations and acronyms used in the report
  • 14. USA Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 15. USA Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 16. France Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 17. France Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 18. Germany Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 19. Germany Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 20. Italy Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 21. Italy Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 22. Spain Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 23. Spain Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 24. United Kingdom Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 25. United Kingdom Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 26. Brazil Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 27. Brazil Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 28. Japan Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 29. Japan Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 30. India Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 31. India Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 32. Mexico Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 33. Mexico Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 34. Turkey Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 35. Turkey Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 36. Netherlands Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 37. Netherlands Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 38. Australia Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 39. Australia Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 40. Canada Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 41. Canada Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
  • 42. Poland Prevalence of Neuropathic Pain by 5-yr age cohort, males (000s)
  • 43. Poland Prevalence of Neuropathic Pain by 5-yr age cohort, females (000s)
Back to Top